The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / O•• P••••••

T••• B••••• Invests in O•• P••••••

Platform acquisitionannouncedannounced Jul 30, 2026Fact
What happened
Target
O•• P••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / healthcare, hospital, medical
Target location
MD, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
Advisory side
  • K••••••• • E•••• L••Legal adviserconfirmed
    “Lazard Frères & Co. LLC served as sole secondary advisor and K••••••• • E•••• L•• served as legal advisor to Blue Sea and O•• P•••••• on the transaction.”
Side not stated
  • J•••• S••••••Managementconfirmed
    ““We are thrilled to continue our partnership with Blue Sea and are well positioned to continue our acquisition strategy and capitalize on the attractive market opportunity before us,” said J•••• S••••••, CEO of O•• P••••••.”
  • O•• P••••••Targetconfirmed
    “T••• B••••• Invests in O•• P••••••”
Evidence
“T••• B••••• Invests in O•• P••••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
T••• B••••• Invests in O•• P•••••• | Private Equity Intelligence | DFX